AstraZeneca prices a $2 billion bond issue
AstraZeneca prices a $2 billion bond issue AstraZeneca PLC announces that yesterday it conducted a successful global bond market transaction issuing a total of $2 billion of notes. The proceeds of the issue will be used for debt refinancing and general corporate purposes. The transaction, which is an SEC-registered global offering, consists of two tranches: $1 billion of 7-year fixed rate notes with a coupon of 1.95% and $1 billion of 30-year fixed rate notes with a coupon of 4%.The notes will be issued under AstraZeneca’s existing automatic shelf registration statement on Form F-3,